Additionally, cancer cells may overexpress several surface receptors, including CD46, ICAM-1 (CD54), DAF (CD55), CD155 and integrins, which enable OVs to enter tumor cells in the TME (29–32). This evidence concerns the gene CD55 and neoplasm.